Natteri Veeraraghavan

From Wikipedia, the free encyclopedia

Natteri Veeraraghavan
Dr.N. VEERARAGHAVAN 1993.jpg
Born1 November 1913
India
Died6 August 2004(2004-08-06) (aged 90)
OccupationMicrobiologist, physician
Known forMicrobiology
Spouse(s)Kamala Veeraraghavan
Parent(s)Natteri Venkatesa Iyer
Balambal
AwardsPadma Shri
Societe Anonyme Poonawalla Memorial Award

Natteri Veeraraghavan (1913-2004) was an Indian physician, microbiologist and medical researcher, known for his contributions to the understanding of diseases like rabies, tuberculosis and leprosy.[citation needed] He was a former director of the Pasteur Institute of India, Coonoor[1] and the chairman of the World Health Organization International Reference Center on Rabies. He was honoured by the Government of India in 1967, with the award of Padma Shri, the fourth highest Indian civilian award for his contributions to the society.[2]

Biography[]

Natteri Veeraraghavan was born in Parangipettai, in Chennai district in the south Indian state of Tamil Nadu on 1 November 1913 to Natteri Venkatesa Iyer and Balambal. His graduated in medicine (MBBChir) from Andhra University in 1936 and did his senior internship at the Government Mental Hospital, Chennai in 1937. His career started as a research officer at the Pasteur Institute of India at Coonoor in 1937 and became the assistant director of the institute in 1941. While working in that position, he secured a doctoral degree (DSc) in microbiology from Andhra University in 1944.[citation needed]

In 1947, Veeraraghavan was made the director of the institute, a post he held till his retirement in 1972. Post retirement, he served as the director of the Vector Control Research Center, Pondicherry, from 1975 to 1977 and as the director of the Voluntary Health Services Medical Centre from 1977.[citation needed] He was a member of the Indian Council of Medical Research from 1945 to 1981 and sat on the Expert Panel of the World Health Organization on Rabies in 1953,[3] 1956,[4] 1959,[5] 1965[6] and 1972.[7] He was the vice chairman of the panel in 1953[3] and the chairman in 1959.[5] He also served as a member of the Indian chapter of the World Health Organization Influenza Center from 1959 to 1972 and the Armed Forces Research Committee from 1967 to 1972.[citation needed]

One of the founding members of the Indian Academy of Medical Sciences,[citation needed] (present day National Academy of Medical Sciences),[8] Veeraraghavan was known to have involved in extensive research in microbiology. He held many patents for his research[9][10][11] and his research findings have been documented by way of several publications.[12] Some of his notable publications are:

  • Studies on Leprosy[13]
  • Studies on Leprosy: Supplement 3[14]
  • In Vitro Cultivation of M. Leprae: An Improved Medium[15]
  • Fluorescent antibody staining of rabies virus antigens using lissamine rhodamine B200 as fluorochrome[16]
  • The value of 5% semple vaccine in human treatment : comparative mortality among the treated and untreated[17]
  • A rapid method for cultivation of M. tuberculosis : an improved medium[18]

Veeraraghavan, a recipient of the Societe Anonyme Poonawalla Memorial Award,[citation needed] was honoured by the Government of India with the civilian award of Padma Shri in 1967.[2] He died at the age of 90 on 6 August 2004,[19] survived by his wife, Kamala, daughter Shantha, and sons, Dr. N.V. Chandran and Dr. Mani Veeraraghavan.[citation needed]

References[]

  1. ^ "Pasteur Institute" (PDF). University of Cincinnati. 2015. Retrieved 9 May 2015.
  2. ^ Jump up to: a b "Padma Shri" (PDF). Padma Shri. 2015. Retrieved 11 November 2014.
  3. ^ Jump up to: a b "WHO report 1953" (PDF). 1953. World Health Organization. Retrieved 9 May 2015.
  4. ^ "WHO report 1956" (PDF). 1956. World Health Organization. Retrieved 9 May 2015.
  5. ^ Jump up to: a b "WHO report" (PDF). December 1959. World Health Organization. Retrieved 9 May 2015.
  6. ^ "WHO report 1965" (PDF). 1965. World Health Organization. Retrieved 9 May 2015.
  7. ^ "WHO report 1972" (PDF). 1972. World Health Organization. Retrieved 9 May 2015.
  8. ^ "National Academy of Medical Sciences". National Academy of Medical Sciences. 2015. Retrieved 9 May 2015.
  9. ^ "Patent Buddy". Patent Buddy. 2015. Retrieved 9 May 2015.
  10. ^ "Free patents online". Free patents online. 2015. Retrieved 9 May 2015.
  11. ^ "Google Patents". Google Patents. 2015. Retrieved 9 May 2015.
  12. ^ "Worldcat Index". Worldcat. 2015. Retrieved 9 May 2015.
  13. ^ Natteri Veeraraghavan (1982). Studies on Leprosy. Voluntary Health Services Medical Centre Research Publication. ASIN B001OMXUVE.
  14. ^ Natteri Veeraraghavan (1988). Studies on Leprosy: Supplement 3. Voluntary Health Services Medical Centre Research Publication. p. 53.
  15. ^ Natteri Veeraraghavan. In Vitro Cultivation of M. Leprae: An Improved Medium. Voluntary Health Services Medical Centre.
  16. ^ N Veeraraghavan; D S Chandrasekhar (1963). "Fluorescent antibody staining of rabies virus antigens using lissamine rhodamine B200 as fluorochrome". International government publication - WHO. OCLC 890850616.CS1 maint: multiple names: authors list (link)
  17. ^ N Veeraraghavan (1963). "The value of 5% semple vaccine in human treatment : comparative mortality among the treated and untreated". International government publication - WHO. OCLC 891353987.
  18. ^ N Veeraraghavan (2000). "A rapid method for cultivation of M. tuberculosis : an improved medium". V.H.S. Medical Centre. OCLC 44655199.
  19. ^ "My Heritage". My Heritage. 2015. Retrieved 9 May 2015.

Further reading[]

  • Natteri Veeraraghavan (1982). Studies on Leprosy. Voluntary Health Services Medical Centre Research Publication. ASIN B001OMXUVE.
  • Natteri Veeraraghavan (1988). Studies on Leprosy: Supplement 3. Voluntary Health Services Medical Centre Research Publication. p. 53.
  • Natteri Veeraraghavan. In Vitro Cultivation of M. Leprae: An Improved Medium. Voluntary Health Services Medical Centre.
  • N Veeraraghavan; D S Chandrasekhar (1963). "Fluorescent antibody staining of rabies virus antigens using lissamine rhodamine B200 as fluorochrome". International government publication - WHO. OCLC 890850616.CS1 maint: multiple names: authors list (link)
  • N Veeraraghavan (1963). "The value of 5% semple vaccine in human treatment : comparative mortality among the treated and untreated". International government publication - WHO. OCLC 891353987.
  • N Veeraraghavan (2000). "A rapid method for cultivation of M. tuberculosis : an improved medium". V.H.S. Medical Centre. OCLC 44655199.
Retrieved from ""